| Safety and efficacy of direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation electrical cardioversion: An update systematic review and meta-analysis. | 2023 | International Journal of Cardiology |
| Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials. | 2023 | European Heart Journal Cardiovascular Pharmacotherapy |
| Cost effectiveness of strategies to manage atrial fibrillation in middle- and high-income countries: a systematic review. | 2023 | PharmacoEconomics |
| Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations. | 2023 | Value in Health Regional Issues |
| The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: A systematic review and meta-analysis. | 2023 | The Anatolian Journal of Cardiology |
| Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis. | 2023 | Medicines |
| Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis | 2023 | https://doi.org/10.1002/14651858.CD010956.pub3 |
| Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism | 2023 | The Cochrane database of systematic reviews |
| Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis | 2023 | Cardiovascular drugs and therapy |
| Non-major bleeding risk of direct oral anticoagulants versus vitamin K antagonists for stroke prevention with atrial fibrillation: a systematic review and network meta-analysis | 2023 | European journal of clinical pharmacology |
| Efficacy and safety of direct oral anticoagulants for the treatment of cancer-associated venous thromboembolism: A systematic review and Bayesian network meta-analysis | 2023 | Medicina clinica |
| Safety outcomes of direct oral anticoagulants in older adults with atrial fibrillation: a systematic review and meta-analysis of (subgroup analyses from) randomized controlled trials | 2023 | GeroScience |
| Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials. | 2022 | Acta Cardiologica |
| A network meta-analysis of direct factor Xa inhibitors for the treatment of cancer-associated venous thromboembolism. | 2022 | Vascular |
| The use of non-vitamin K oral anticoagulants in dialysis patients—A systematic review. | 2022 | Seminars in Dialysis |
| Cost-effectiveness of New Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in Low and Middle-Income Countries: A Systematic Review. | 2022 | Medical Journal of the Islamic Republic of Iran |
| Short-term efficacy and safety of edoxaban for venous thromboembolism after total hip or knee arthroplasty: a systematic review and meta-analysis. | 2022 | European Review for Medical and Pharmacological Sciences |
| Optimal stroke preventive strategy for patients aged 80 years or older with atrial fibrillation: a systematic review with traditional and network meta-analysis. | 2022 | Age and Ageing |
| Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis. | 2022 | Future Cardiology |
| Direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and network meta-analysis | 2022 | Supportive care in cancer |
| Efficacy and Safety of Oral Anticoagulants for Atrial Fibrillation Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis | 2022 | Frontiers in cardiovascular medicine |
| Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis | 2022 | Frontiers in cardiovascular medicine |
| Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis | 2022 | Mayo Clinic proceedings |
| Non-vitamin K antagonist oral anticoagulants in venous thromboembolism patients: a meta-analysis of real-world studies | 2022 | BMC cardiovascular disorders |
| Comparative Effects Between Direct Oral Anticoagulants for Acute Venous Thromboembolism: Indirect Comparison From Randomized Controlled Trials | 2022 | Frontiers in medicine |
| Comparative Safety and Efficacy of Eight Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention | 2022 | Frontiers in cardiovascular medicine |
| The association of fracture risk in atrial fibrillation patients and longterm anticoagulant therapy category: a systematic review and meta-analysis. | 2021 | PeerJ |
| Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta analysis of randomized controlled trials. | 2021 | Journal of Neurology |
| Warfarin versus DOACs in the prevention of thromboembolic stroke in patients with Afib. | 2021 | Lynchburg Journal of Medical Science |
| Major gastrointestinal bleeding risk with direct oral anticoagulants: Does type and dose matter? A systematic review and network meta-analysis. | 2021 | European Journal of Gastroenterology & Hepatology |
| Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: a systematic review and a network meta-analysis. | 2021 | Pharmacological Research |
| Oral anticoagulant agents in patients with atrial fibrillation and CKD: a systematic review and pairwise network meta-analysis. | 2021 | American Journal of Kidney Diseases |
| The risk of gastrointestinal bleeding between non-vitamin K antagonist oral anticoagulants and vitamin K antagonists in the Asian atrial fibrillation patients: a meta-analysis. | 2021 | International Journal of Environmental Research and Public Health |
| The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants: a network meta-analysis. | 2021 | Medicine |
| A network meta-analysis comparing osteoporotic fracture among different direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation. | 2021 | Journal of Bone Metabolism |
| Pharmacogenetics of direct oral anticoagulants: a systematic review. | 2021 | Journal of Personalized Medicine |
| Is chemoprophylaxis required after total knee and total hip arthroplasty in the Asian population? A systematic review and network meta-analysis. | 2021 | Thrombosis Research |
| Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients. | 2021 | Cardiovascular Pharmacotherapy |
| Risk of stroke and bleeding in relation to hypertension in anticoagulated patients with atrial fibrillation: a meta-analysis of randomised controlled trials. | 2021 | Acta Cardiologica |
| Efficacy and safety of anticoagulants for postoperative thrombophylaxis in total hip and knee arthroplasty: a PRISMA-compliant Bayesian network meta-analysis. | 2021 | PLoS One |
| Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation. | 2021 | NICE |
| The efficacy and safety of edoxaban versus warfarin in preventing clinical events in atrial fibrillation: a systematic review and meta-analysis. | 2021 | The Anatolian Journal of Cardiology |
| Oral anticoagulant agents in patients with atrial fibrillation and CKD: a systematic review and pairwise network meta-analysis. | 2021 | American Journal of Kidney Disease |
| Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis. | 2021 | BMJ Evidence-Based Medicine |
| A network meta-analysis of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and diabetes mellitus. | 2021 | Acta Cardiologica |
| Effectiveness of Direct Oral Anticoagulants in Obese Adults With Atrial Fibrillation: A Systematic Review of Systematic Reviews and Meta-Analysis | 2021 | Frontiers in cardiovascular medicine |
| Reasons for discontinuing oral anticoagulation therapy for atrial fibrillation: a systematic review | 2021 | Age and ageing |
| Impact of Age, Sex, and Renal Function on the Efficacy and Safety of Direct Oral Anticoagulants vs. Vitamin K Antagonists for the Treatment of Acute Venous Thromboembolism: A Meta-Analysis of 22,040 Patients | 2021 | Frontiers in cardiovascular medicine |
| Reappraisal of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Systematic Review and Meta-Analysis | 2021 | Frontiers in cardiovascular medicine |
| Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients | 2021 | European heart journal |
| Comparative efficacy and safety of warfarin care bundles and novel oral anticoagulants in patients with atrial fibrillation: a systematic review and network meta-analysis. | 2020 | Scientific Reports |
| The role of non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A PRISMA-compliant article | 2020 | Medicine |
| Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data | 2020 | Heart failure reviews |
| Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis | 2020 | Thrombosis and haemostasis |
| Efficacy and Safety of Direct Oral Anticoagulants in Elderly Patients With Atrial Fibrillation: A Network Meta-Analysis | 2020 | Frontiers in medicine |
| Net Clinical Benefit of Direct Oral Anticoagulants in Patients With Cancer and Venous Thromboembolism: A Systematic Review and Trade-Off Analysis | 2020 | Frontiers in cardiovascular medicine |
| Safety and Efficacy of Oral Anticoagulants Therapies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-Analysis | 2020 | Journal of cardiovascular pharmacology and therapeutics |
| Non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: a systematic review with meta-analysis and trial sequential analysis. | 2019 | Archives of Gerontology and Geriatrics |
| Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis | 2019 | Journal of thrombosis and haemostasis |
| Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: a network meta-analysis | 2019 | Scandinavian cardiovascular journal |
| Direct Oral Factor Xa Inhibitors for the Treatment of Acute Cancer-Associated Venous Thromboembolism: A Systematic Review and Network Meta-analysis | 2019 | Mayo Clinic proceedings |
| Elderly Bleeding Risk of Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Cohort Studies | 2019 | Drugs in R&D |
| Interventions for preventing thromboembolic events in patients with atrial fibrillation: a systematic review. | 2018 | Annals of Internal Medicine |
| Stroke prevention in patients with atrial fibrillation: a systematic review update. | 2018 | Agency for Healthcare Research and Quality |
| Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation. | 2018 | Cochrane Database of Systematic Reviews |
| Causes of Death in Patients with Venous Thromboembolism Anticoagulated with Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis | 2018 | Seminars in thrombosis and hemostasis |
| Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis | 2018 | Current medical research and opinion |
